We are live on
!
Find out more
CM
Crestline Management Portfolio holdings
AUM
$46.3M
1-Year Est. Return
48.82%
This Fund
S&P 500
This Quarter
Est. Return
-7.09%
1 Year Est. Return
+48.82%
3 Year Est. Return
+52.52%
5 Year Est. Return
+37.91%
10 Year Est. Return
+316.44%
AUM
$952M
AUM Growth
+$148M
(+18%)
Cap. Flow
+$242M
Cap. Flow
% of AUM
25.41%
Top 10 Holdings %
Top 10 Hldgs %
41.49%
Holding
321
New
111
Increased
81
Reduced
33
Closed
93
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Affiliated Managers Group
AMG
|
+$12.2M |
| 2 |
ATH
Athene Holding Ltd. Class A Common Shares
ATH
|
+$11.9M |
| 3 |
Jefferies Financial Group
JEF
|
+$10.2M |
| 4 |
SEI Investments
SEIC
|
+$10.1M |
| 5 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$8.58M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$14.2M |
| 2 |
Assurant
AIZ
|
+$8.7M |
| 3 |
Principal Financial Group
PFG
|
+$8.66M |
| 4 |
CME Group
CME
|
+$6.58M |
| 5 |
Voya Financial
VOYA
|
+$5.48M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 42.54% |
| 2 | Financials | 13.82% |
| 3 | Technology | 12.96% |
| 4 | Industrials | 10.18% |
| 5 | Real Estate | 7.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CALA
226
DELISTED
Calithera Biosciences, Inc
CALA
| $435K | 0.05% |
4,347
+1,343
| +45% | +$152K |
|
|
CCXI
227
DELISTED
ChemoCentryx, Inc.
CCXI
| $257K | 0.03% |
+19,514
| New | +$233K |
|
228
Syndax Pharmaceuticals
SNDX
$1.69B
| $246K | 0.03% |
35,027
-1,687
| -5% | -$16.6K |
|
|
AFMD
229
DELISTED
Affimed
AFMD
| – | – |
-33,417
| Closed | -$618K |
|
|
230
Assurant
AIZ
$13.8B
| – | – |
-95,183
| Closed | -$8.7M |
|
231
Arthur J. Gallagher & Co
AJG
$64.1B
| – | – |
-39,902
| Closed | -$2.74M |
|
232
Advanced Micro Devices
AMD
$776B
| – | – |
-113,965
| Closed | -$1.15M |
|
233
American Homes 4 Rent
AMH
$12B
| – | – |
-12,702
| Closed | -$255K |
|
234
Ameriprise Financial
AMP
$48.3B
| – | – |
-21,116
| Closed | -$3.12M |
|
235
Aon
AON
$76.5B
| – | – |
-26,509
| Closed | -$3.72M |
|
236
Ardelyx
ARDX
$1.22B
| – | – |
-299,750
| Closed | -$1.51M |
|
237
Arrow Electronics
ARW
$11.1B
| – | – |
-10,000
| Closed | -$770K |
|
238
Astronics
ATRO
$3.43B
| – | – |
-43,906
| Closed | -$1.19M |
|
239
AXIS Capital
AXS
$7.68B
| – | – |
-90,532
| Closed | -$5.21M |
|
|
BNY
240
Bank of New York Mellon
BNY
$106B
| – | – |
-39,258
| Closed | -$2.02M |
|
241
BlackLine
BL
$1.84B
| – | – |
-14,822
| Closed | -$581K |
|
242
Brown & Brown
BRO
$23.6B
| – | – |
-28,940
| Closed | -$736K |
|
243
Brixmor Property Group
BRX
$9.67B
| – | – |
-117,433
| Closed | -$1.79M |
|
244
British American Tobacco
BTI
$131B
| – | – |
-58,000
| Closed | -$3.35M |
|
245
Cheesecake Factory
CAKE
$5.04B
| – | – |
-33,919
| Closed | -$1.64M |
|
|
CDTX
246
DELISTED
Cidara Therapeutics
CDTX
| – | – |
-1,952
| Closed | -$156K |
|
247
Celestica
CLS
$38.1B
| – | – |
-60,000
| Closed | -$621K |
|
248
Comcast
CMCSA
$85B
| – | – |
-59,000
| Closed | -$2.02M |
|
|
249
CME Group
CME
$96.3B
| – | – |
-40,687
| Closed | -$6.58M |
|
250
Equity Residential
EQR
$24.9B
| – | – |
-13,648
| Closed | -$841K |
|
Similar funds
MCMC
RRC
PCM
NPCM
FCM
EGI
IPHI
SM
Crestline Management's Q2 2018 Portfolio in Review
As of Q2 2018, Crestline Management held 321 positions worth $952M, up 18% from $804M the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Crestline Management deployed $242M of net new capital in Q2 2018, opening 111 new positions and adding to 81 existing holdings. Its largest new stake was Affiliated Managers Group: 73,871 shares worth $11M.
By sector, the portfolio is most concentrated in Healthcare at 43% of assets, down from 56% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Voya Financial, an estimated $5.48M trimmed.
- Crestline Management's largest Q2 2018 buy was Affiliated Managers Group: 73,871 shares worth $11M.
- Crestline Management added most to IHS Markit Ltd. Common Shares in Q2 2018, an estimated $8.58M increase.
- Crestline Management's biggest Q2 2018 reduction was Voya Financial, cutting an estimated $5.48M.
- Crestline Management fully exited Visa in Q2 2018, selling an estimated $14.2M.
- Crestline Management's ten largest holdings make up 41% of its $952M portfolio in Q2 2018.
- Crestline Management opened 111 new positions and closed 93 in Q2 2018.
- Crestline Management's portfolio value rose 18% quarter-over-quarter to $952M.
Based on Crestline Management's 13F filing for Q2 2018, filed 14 Aug 2018.